Study Reveals How Mitochondrial Damage in Muscle Fuels Diabetes Progression
A new study has revealed critical insights into how impaired mitochondrial dynamics and quality control mechanisms in skeletal muscle influence insulin sensitivity in patients with Type 2 Diabetes. The findings are published in the Journal of Cachexia, Sarcopenia and Muscle.
The research team focused on the significance of deubiquitinating enzymes, or DUBs, in regulating mitochondrial dynamics within skeletal muscle.
Findings suggest that mitochondrial fragmentation can bypass defects in mitophagy, the process by which cells remove damaged mitochondria, to sustain skeletal muscle quality control in patients with Type 2 Diabetes.
This adaptation may help maintain mitochondrial function despite impaired mitophagy.
In other words, the study shows that people with Type 2 Diabetes have fewer healthy mitochondria, the parts of the cell that produce energy, because a certain protein - dynamin-related protein 1, or DRP1 - is working too much.
In addition, another group of proteins - DUBs - are shown to interfere with a process that helps the body clean up damaged mitochondria.
This interference makes it harder for muscles to use insulin properly, which is a key issue in diabetes.
The research findings advance the understanding of how impaired mitochondrial dynamics and quality control may contribute to skeletal muscle insulin resistance and the manifestation of Type 2 Diabetes, and also provides key evidence that DUB antagonists may play an important role in preventing or treating Type 2 Diabetes.
"Our research team examined how certain enzymes affect mitochondria in muscle cells of people with diabetes," said Dr. Kirwan, Executive Director and George A. Bray, Jr. Endowed Super Chair in Nutrition at Pennington Biomedical. "We found that when the normal cleanup process for damaged mitochondria isn't working well, the cells adapt by breaking mitochondria into smaller pieces. This alternative approach helps maintain muscle function despite the metabolic challenges of Type 2 diabetes. Our study highlights the complex interplay between mitochondria and insulin, paving the way for future interventions aimed at improving metabolic health."
Reference: https://www.pbrc.edu//news/media/2025/journal-of-cachexia-sarcopenia-and-muscle.aspx
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.